Aclaris Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2014 to Q3 2024.
  • Aclaris Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$10.5M, a 66.8% increase year-over-year.
  • Aclaris Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$46.3M, a 62.2% increase year-over-year.
  • Aclaris Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$97.4M, a 8.35% decline from 2022.
  • Aclaris Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$89.9M, a 0.15% decline from 2021.
  • Aclaris Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$89.7M, a 76.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$46.3M -$10.5M +$21.1M +66.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$67.4M -$12.9M +$19M +59.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$86.4M -$18.9M +$11M +36.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$97.4M -$4.05M +$25M +86.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$122M -$31.6M -$10.7M -51.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$112M -$31.8M -$10.8M -51.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$101M -$29.9M -$11M -58.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$89.9M -$29.1M -$6.19M -27% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$83.7M -$20.9M -$579K -2.85% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$83.1M -$21M -$2.99M -16.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$80.1M -$18.9M +$9.62M +33.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$89.7M -$22.9M -$9.33M -68.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$80.4M -$20.3M -$9.83M -93.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$70.6M -$18M -$6.63M -58.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$63.9M -$28.5M -$13M -84% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$50.9M -$13.6M +$3.98M +22.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$54.9M -$10.5M +$12.4M +54.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$67.3M -$11.4M +$32.2M +73.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$99.5M -$15.5M +$11.5M +42.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$111M -$17.5M -$17M -3326% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$94M -$22.9M -$1.52M -7.13% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$92.5M -$43.6M -$11.6M -36.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$80.9M -$27.1M +$3.9M +12.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$84.8M -$512K +$6.87M +93.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$91.6M -$21.3M -$2.59M -13.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$89.1M -$32M -$16.7M -109% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$72.4M -$30.9M -$18M -139% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$54.4M -$7.38M +$4.25M +36.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 -$58.6M -$18.8M -$7.94M -73.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$50.7M -$15.3M -$2.31M -17.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$48.4M -$12.9M +$209K +1.59% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$48.6M -$11.6M -$6.83M -142% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 -$41.7M -$10.8M -$172K -1.62% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$41.6M -$13M -$10.4M -400% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$31.2M -$13.1M -$10.5M -400% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$20.7M -$4.8M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 -$10.6M -$7.98M -300% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$2.6M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$2.63M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q3 2014 -$2.66M Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-12-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.